Medical Research

Latest stories

More stories

  • Mecbotamab Vedotin Unlocks New Hope for Extended Survival in Treatment Refractory Soft Tumors

    Breaking Ground in Soft Tissue Sarcoma Treatment: A Closer Look at Mecbotamab Vedotin The field of oncology never stops evolving, and recently, a new chapter has been written with the promising data on Mecbotamab Vedotin (Mec‑V). As an antibody‐drug conjugate (ADC) targeting the AXL protein, Mec‑V has shown encouraging potential in extending survival for patients […] More

  • Breakthrough advances in cancer treatment with novel compounds

    Reimagining Cancer Treatment: A Bold New Frontier in Modern Medicine Recent breakthroughs at the University of Florida have set off waves of excitement in the healthcare community as researchers introduce innovative compounds that enhance the response of cancer cells to treatment. This pioneering work is reshaping our understanding of how modern medicine can target deadly […] More

  • Exploring Acupuncture Benefits For Autism Through Target Trial Emulation

    Introduction The integration of modern methodologies and traditional practices in healthcare is an evolving topic that continues to gain traction. Recently, the application of target trial emulation (TTE) to evaluate acupuncture combined with rehabilitation therapy for children with autism spectrum disorder (ASD) has sparked considerable discussion. This editorial offers an opinion on this emerging research […] More

  • Unexpected spread of prostate cancer to the anterior urethra from minimal PSA elevation

    Enhancing Trust in Healthcare Websites Through Digital Security In today’s rapidly evolving digital landscape, online healthcare portals have become a cornerstone for patients seeking reliable medical information, guidance, and even treatment options. However, the journey from browsing to trusting these online spaces can be filled with tricky parts and confusing bits. Ensuring that every visitor […] More

  • Innovative Synthesis of Selanyl Phenyl Compounds through Fragment Merging Approach

    The Convergence of Online Verification and Healthcare Security At first glance, the message “Verifying you are human. This may take a few seconds. Verification successful” might seem like a standard checkpoint used on many websites. However, beneath these seemingly routine words lies a layered story of cybersecurity that has become particularly important in the realm […] More

  • Chronic Hepatitis C Emerges as a Hidden Catalyst for Deadly Cancer

    Chronic Hepatitis C and Pancreatic Cancer: Uncovering the Hidden Links The debate about the tricky parts of modern medicine never seems to rest. Recent research has thrown a spotlight on chronic hepatitis C (HCV) and its connection to pancreatic ductal adenocarcinoma (PDAC). While this study looked specifically at a large group of U.S. veterans, it […] More

  • Jason Hafron MD Shares Groundbreaking Prostate Cancer Insights from ESMO 2025

    Prostate Cancer Treatment Updates at ESMO 2025: A Transformative Outlook The 2025 European Society for Medical Oncology (ESMO) Congress in Berlin brought forward a wave of exciting updates in prostate cancer treatment. As a long-time observer and advocate for improving patient outcomes, I find that the new data from trials such as EMBARK, PSMAddition, and […] More

  • Melanoma Breakthroughs Unleashing New Hope for Patients in 2025

    Melanoma Cure Rate: A Paradigm Shift in Cancer Treatment Melanoma, often recognized as the most aggressive form of skin cancer, has long been synonymous with high mortality despite representing only a small fraction of skin cancer cases. As an opinion piece, this article examines melanoma cure rates from multiple angles—including early detection, surgery, immunotherapy, and […] More

  • Foster Returns to Stanford to Spearhead Innovative Surgical Cancer Research

    A Return to Stanford: Merging Surgical Expertise and Breakthrough Research in Cancer Care Over the past few years, Deshka Foster, MD, PhD, has made headlines by returning to her alma mater, Stanford, to lead an innovative surgical research program. Her journey is a vivid example of how combining hands-on clinical experience with laboratory research can […] More

  • Discus Trial Redefines Platinum Chemotherapy Duration in Advanced Urothelial Cancer

    Reevaluating Treatment Duration in Advanced Urothelial Carcinoma The DISCUS trial introduces a new way of looking at treatment routines in advanced urothelial carcinoma. In an era dominated by immunotherapy, medical experts are beginning to question the old standard of delivering six full cycles of platinum-based chemotherapy before starting maintenance with immunotherapy. Recent study findings suggest […] More

Load More
Congratulations. You've reached the end of the internet.